Get startedLog in
    Picture of Redwood Pharma AB logo

    REDW — Redwood Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Redwood Pharma Receives Approval From The Austrian Drug Authority To Start Rp501 Clinical Trial

    Picture of Redwood Pharma AB logoRedwood Pharma AB
    28/03/2022 15:21
    March 28 (Reuters) - Redwood Pharma AB  REDWPH.ST :
    * REDWOOD PHARMA RECEIVES APPROVAL FROM THE AUSTRIAN DRUG
AUTHORITY TO START RP501 CLINICAL TRIAL
    * FOLLOWING APPROVAL FROM AUSTRIAN ETHICS COMMISSION EARLIER
THIS
MONTH, THIS IS SECOND AND FINAL APPROVAL REQUIRED FOR COMPANY TO
BEGIN CLINICAL WORK

Source text for Eikon:  ID:nWkrDBMHV 
Further company coverage:  REDWPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Redwood Pharma AB

    See all news